Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell Lung Extensive Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00453154
What this trial is testing

Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaRecurrent Lung Small Cell Carcinoma
National Cancer Institute (NCI) 156
Early research (Phase 1)Study completedNCT01840579
What this trial is testing

Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011)

Who this might be right for
Solid TumorNon-small Cell Lung CancerSmall Cell Lung Cancer
Merck Sharp & Dohme LLC 57
Testing effectiveness (Phase 2)Study completedNCT00403403
What this trial is testing

Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE)

Who this might be right for
Small Cell Lung Cancer
Genentech, Inc. 102
Testing effectiveness (Phase 2)Study completedNCT00282022
What this trial is testing

VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vion Pharmaceuticals 87
Testing effectiveness (Phase 2)Ended earlyNCT02161419
What this trial is testing

RONICICLIB / Placebo in Combination With Chemotherapy in Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Bayer 142
Not applicableNot Yet RecruitingNCT07670442
What this trial is testing

Epigenomic Profiling of Circulating Cell-Free DNA (cfDNA) to Characterize the Dynamic Evolution of Molecular Subtypes in Extensive-Stage Small Cell Lung Cancer During First-Line Chemoimmunotherapy

Who this might be right for
Small Cell Lung Cancer
Assistance Publique - Hôpitaux de Paris 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04607954
What this trial is testing

Durvalumab and Lurbinectedin for the Treatment of Relapsed or Refractory Small Cell Lung Cancer

Who this might be right for
Platinum-Resistant Lung Small Cell CarcinomaPlatinum-Sensitive Lung Small Cell CarcinomaRecurrent Extensive Stage Lung Small Cell Carcinoma+1 more
Mayo Clinic 29
Not applicableLooking for participantsNCT05945745
What this trial is testing

Molecular Analysis and Treatment Options of SCLC

Who this might be right for
Small-cell Lung CancerSmall Cell Lung Cancer, Combined TypeSmall Cell Lung Carcinoma+2 more
Shanghai Chest Hospital 500
Testing effectiveness (Phase 2)Study completedNCT00078845
What this trial is testing

Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors

Who this might be right for
Breast CancerLung CancerNeurotoxicity+3 more
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT02323737
What this trial is testing

Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Chinese Academy of Medical Sciences 62
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06851819
What this trial is testing

Tislelizumab in Combination with Chemotherapy ± Radiotherapy for Extensive-Stage Oligometastatic Small Cell Lung Cancer.

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Hebei Medical University Fourth Hospital 64
Testing effectiveness (Phase 2)Ended earlyNCT02899728
What this trial is testing

Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell Carcinoma
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Looking for participantsNCT05068232
What this trial is testing

Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)

Who this might be right for
Small-cell Lung CancerExtensive-stage Small-cell Lung CancerLung Cancer
University of Chicago 49
Not applicableStudy completedNCT06826677
What this trial is testing

REAL-WORLD DURVALUMAB IN EXTENSIVE-STAGE SMALL CELL LUNG CANCER

Who this might be right for
Small Cell Lung Carcinoma
AstraZeneca 71
Testing effectiveness (Phase 2)Looking for participantsNCT07654400
What this trial is testing

BL-M14D1 in Combination With Atezolizumab in Patients With Extensive-stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 36
Testing effectiveness (Phase 2)UnknownNCT02171325
What this trial is testing

Study of Different Doses of Irinotecan and Cisplatin for First-line Extensive-stage Small-cell Lung Cancer Treatment

Who this might be right for
Small Cell Lung Cancer
Guangdong Association of Clinical Trials 54
Testing effectiveness (Phase 2)Study completedNCT00068289
What this trial is testing

Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

Who this might be right for
Lung Cancer
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Looking for participantsNCT06362252
What this trial is testing

I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)

Who this might be right for
Extensive Stage-small Cell Lung Cancer
Daiichi Sankyo 123
Testing effectiveness (Phase 2)Study completedNCT02514447
What this trial is testing

Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy

Who this might be right for
Small Cell Lung Cancer
G1 Therapeutics, Inc. 123
Testing effectiveness (Phase 2)Ended earlyNCT00702962
What this trial is testing

Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Milton S. Hershey Medical Center 8
Next Page